PMV Pharmaceuticals Inc.
(PMVP)
undefined
undefined%
At close: undefined
1.58
-0.32%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Revenue | - | - | - | - | - | - |
Cost of Revenue | 1.26M | 650.00K | 1.28M | 318.00K | 388.00K | 338.00K |
Gross Profit | -1.26M | -650.00K | -1.28M | -318.00K | -388.00K | -338.00K |
Operating Income | -80.13M | -77.04M | -58.29M | -34.94M | -26.64M | -18.89M |
Interest Income | 11.17M | 3.63M | 449.00K | 651.00K | 1.30M | 1.34M |
Pretax Income | -68.96M | -73.33M | -57.82M | -34.43M | -25.34M | -17.54M |
Net Income | -68.96M | -73.32M | -57.85M | -34.44M | -25.35M | -17.54M |
Selling & General & Admin | 24.25M | 25.05M | 21.80M | 11.01M | 5.88M | 5.04M |
Research & Development | 55.88M | 51.99M | 36.49M | 23.93M | 20.76M | 13.85M |
Other Expenses | - | 87.00K | 21.00K | -143.00K | -8.00K | 16.00K |
Operating Expenses | 80.13M | 77.04M | 58.29M | 34.94M | 26.64M | 18.89M |
Interest Expense | - | - | - | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - | - |
Cost & Expenses | 80.13M | 77.04M | 58.29M | 34.94M | 26.64M | 18.89M |
Income Tax | 2.00K | -9.00K | 23.00K | 6.00K | 8.00K | 3.00K |
Shares Outstanding (Basic) | 48.01M | 45.59M | 45.14M | 44.78M | 43.00M | 31.23M |
Shares Outstanding (Diluted) | 48.01M | 45.59M | 45.14M | 44.78M | 43.00M | 31.23M |
EPS (Basic) | -1.44 | -1.61 | -1.28 | -0.77 | -0.59 | -0.56 |
EPS (Diluted) | -1.44 | -1.61 | -1.28 | -0.77 | -0.59 | -0.56 |
EBITDA | -78.88M | -76.72M | -57.99M | -34.62M | -26.25M | -18.55M |
Depreciation & Amortization | 1.26M | 650.00K | 1.28M | 318.00K | 388.00K | 338.00K |